Identifying drivers of pertussis disease resurgence pilot study: Final report
Campbell, P. T.; Choi, Y. H.; Gambhir, M.; McVernon, J.
Show abstract
Three separate transmission models were developed to investigate the drivers of pertussis resurgence in the United States (US), United Kingdom (UK) and Australia. While these models were all able to reproduce pertussis trends in the setting for which they were developed, they include different assumptions about infection, immunity and vaccination, reflecting the uncertainties of pertussis epidemiology. A key question is whether, despite these differences, these models produce consistent results across settings with diverse vaccination schedules, epidemiologic histories and surveillance systems. A pilot study was conducted in 2016 for the World Health Organization to examine whether findings from the US, UK and Australian models were generalisable to other country contexts. In Stage I of the study, each of the UK, US and Australian models was applied to the other two settings, using the previously identified best fitting parameter sets. The major aim of this phase was to determine whether there is overall evidence that the models may be applied to high-income countries with long histories of pertussis vaccination. In Stage II of the study, each of the UK, US and Australian models was fitted to the other two settings using the same model selection techniques originally applied, to evaluate consistency of model results and identify broadly congruent characteristics of pertussis transmission and immunity. A major aim of this phase was to determine whether, for a given country, the different models provided similar reasons for pertussis resurgence. Each of the models worked well in the setting for which they were designed, but were not able to capture all of the epidemiologic features in different countries. Limited availability of historical data on vaccination, age-specific burden of disease and the relationship between infection and disease is likely to make fitting of the models to other settings without adaptation challenging.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework 97%
- Exploring the role of mass immunisation in influenza pandemic preparedness: a modelling study for the UK context 96%
- Measuring the impact of COVID-19 vaccination and immunity waning: a modelling study for Portugal 95%
Similar papers in this journal
Similar papers in this journal
- Analysis of host immunological response of adenovirus-based COVID-19 vaccines 96%
- Fall 2021 Resurgence and COVID-19 Seroprevalence in Canada Modelling waning and boosting COVID-19 immunity in Canada A Canadian Immunization Research Network Study 96%
- Modeling the impact of COVID-19 vaccination in Lebanon: A call to speed-up vaccine roll out 95%
Similar papers in this journal
- Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2 97%
- Comparing alternative cholera vaccination strategies in Maela refugee camp using a transmission model 95%
- Modelling the impact of hybrid immunity on future COVID-19 epidemic waves 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.